Biogen Idec Inc. (NASDAQ:BIIB) announced it will report first quarter 2014 financial results on Wednesday, April 23, 2014, before the financial markets open. Biogen Idec Inc (NASDAQ:BIIB) stock performance was 1.28% in last session and finished the day at $309.79. Traded volume was 1.71million shares in the last session and the average volume of the stock remained 1.63million shares. The beta of the stock remained 1.03. Biogen Idec Inc (NASDAQ:BIIB) insider ownership is 0.10%.
The major cosmetics and toiletry companies, including Cincinnati-based Procter & Gamble Co. (NYSE:PG), have said they plan to cut out microbeads in their products, a process that could take more than two years. Sea salt could be an alternative to microbeads, although it’s unclear if a change would impact product costs. The Procter & Gamble Company (NYSE:PG) dropped -0.32 percent to $80.34 Tuesday on volume of 8.22million shares. The intra-day range of the stock was $80.21 to $80.84. The Procter & Gamble Company (NYSE:PG) has a market capitalization of $217.83billion.
Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation at the Cowen and Company 34th Annual Health Care Conference. Epizyme Inc (NASDAQ:EPZM)’s stock on Apr 01, 2014 reported a increase of 4.17% to the closing price of $23.72. Its fifty two weeks range is $18.10 -$45.72. The total market capitalization recorded $749.98million. The overall volume in the last trading session was 284.00K shares. In its share capital, EPZM has 32.75million outstanding shares.
Johnson & Johnson (NYSE:JNJ) announced it has entered a multi-year agreement to be the Official Healthcare Partner of the USO. The announcement was made today during a ceremony to mark the opening of the USO’s Warrior and Family Center at Bethesda, located on the campus of Naval Support Activity Bethesda, home of Walter Reed National Military Medical Center. On Tuesday, shares of Johnson & Johnson (NYSE:JNJ) dropped -0.30% to close the day at $97.94. Company return on investment (ROI) is 15.00% and its monthly performance is recorded as 6.97%. Johnson & Johnson (NYSE:JNJ) quarterly revenue growth is 6.87%.